1999
DOI: 10.11150/kansenshogakuzasshi1970.73.1
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of a New Laboratory Test Measuring Plasma (1-3)-^|^beta;-D-glucan in the Diagnosis of Candida Deep Mycosis

Abstract: We evaluated the effectiveness of the newly developed WAKOTM ƒÀ-glucan test which measures plasma (1•¨3)-ƒÀ-D-glucan concentrations in the diagnosis of Candida deep mycosis. This test was compared to the Cand-Tec test. The WAKOTM ƒÀ-glucan test and Cand-Tec test were performed on 212 plasma specimens which were taken at 212 instances from 62 immunocompromised patients with serious diseases ;.e. hematopoietic malignancy, solid malignant tumor, etc. The sensitivities and specificities for the WAKOTM ƒÀ-glucan te… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
10
0

Year Published

2001
2001
2012
2012

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 0 publications
0
10
0
Order By: Relevance
“…This is due, in part, to the ability of these carbohydrate ligands to activate proinflammatory and immunoregulatory signaling pathways (NF-B and NF-interleukin 6 [NF-IL-6]) in immune competent cells by interacting with specific receptors (1-3, 26, 48). Recent data indicate that glucans are released from fungal cell walls into the systemic circulation of patients with systemic or deep fungal infections (14,23,28). It is not clear whether these circulating fungal polymers induce any of the sequelae associated with fungal infections.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…This is due, in part, to the ability of these carbohydrate ligands to activate proinflammatory and immunoregulatory signaling pathways (NF-B and NF-interleukin 6 [NF-IL-6]) in immune competent cells by interacting with specific receptors (1-3, 26, 48). Recent data indicate that glucans are released from fungal cell walls into the systemic circulation of patients with systemic or deep fungal infections (14,23,28). It is not clear whether these circulating fungal polymers induce any of the sequelae associated with fungal infections.…”
mentioning
confidence: 99%
“…Glucans are also released from the microbial cell wall as exopolymers (14,23,28,37). Numerous studies have demonstrated that (133)-␤-D-glucans will activate a wide array of innate host defenses (4,50).…”
mentioning
confidence: 99%
“…Glucans are also released or actively secreted from the cell wall as exopolymers (1,5,7). Of greater significance, glucans are reported to be released into the blood of patients with fungal infections (1,5,7).…”
mentioning
confidence: 99%
“…Glucans are also released or actively secreted from the cell wall as exopolymers (1,5,7). Of greater significance, glucans are reported to be released into the blood of patients with fungal infections (1,5,7). Since glucans are evolutionarily conserved in microorganisms and are not produced by higher species, including humans, the presence of fungal cell wall glucan in the blood is presumed to be indicative of the presence of a pathogen.…”
mentioning
confidence: 99%
“…Those investigators also reported that modulation of cellular activity by glucan did not depend on internalization. However, they did not establish the mechanisms of internalization, nor did they investigate internalization/trafficking of water-soluble glucans, such as those that circulate in the plasma of patients with active fungal infections (Mori et al, 1997;Nakamura et al, 1998;Hiyoshi et al, 1999;Digby et al, 2003) or the soluble glucans that have been investigated as biopharmaceuticals (Aarsaether et al, 2006). In addition, it is well known that some fungal pathogens, whose cell walls are rich in glucans, are capable of parasitizing and, indeed, living within macrophages where they avoid lysosomal degradation and intracellular killing (Bodey, 2000).…”
Section: Introductionmentioning
confidence: 99%